Significant single agent anti-tumor activity was observed, and cytokine and immune cell profiling provided evidence of prolonged activation of innate and adaptive immune cells in tumor and tumor-draining lymph nodes, with evidence of an increase in the frequency of tumor-antigen specific CD8+ T cells in the TME. Here, CD8A is linked to neoplasm.